XML 31 R5.htm IDEA: XBRL DOCUMENT v3.22.4
Consolidated Statements of Shareholders' Equity - USD ($)
$ in Thousands
Total
Ordinary Shares
Deferred Shares
Additional Paid-in Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Series A Convertible Preferred Shares
Series B Convertible Preferred Shares
Series B Convertible Preferred Shares
Additional Paid-in Capital
Series C Convertible Preferred Shares
Series C Convertible Preferred Shares
Additional Paid-in Capital
Beginning balance at Dec. 31, 2019 $ 101,348 $ 4 $ 1 $ 117,968 $ 8,109 $ (24,813)          
Beginning balance, shares at Dec. 31, 2019             28,250,000 34,794,714      
Beginning balance at Dec. 31, 2019             $ 36 $ 43      
Beginning balance, shares at Dec. 31, 2019   2,534,207 991,865                
Issuance of convertible preferred shares, net of issuance costs               $ 23   $ 32  
Issuance of convertible preferred shares, net of issuance costs, shares               17,397,356   24,412,603  
Issuance of convertible preferred shares, net of issuance costs               $ 44,124 $ 44,101 $ 69,894 $ 69,862
Issuance of ordinary shares (Note 7)   $ 2   (2)              
Issuance of ordinary shares (Note 7), shares   1,993,503                  
Conversion of ordinary shares into deferred shares     $ 1 (1)              
Conversion of ordinary shares into deferred shares, share   (137,790) 548,040                
Repurchase of deferred shares     $ (2) 2              
Repurchase of deferred shares, shares     (1,509,384)                
Share-based compensation expense 2,992     2,992              
Unrealized gain on foreign currency translation 4,213       4,213            
Net loss (33,199)         (33,199)          
Ending balance at Dec. 31, 2020 189,372 $ 6   234,922 12,322 (58,012)          
Ending balance, shares at Dec. 31, 2020             28,250,000 52,192,070   24,412,603  
Ending balance at Dec. 31, 2020             $ 36 $ 66   $ 32  
Ending balance, shares at Dec. 31, 2020   4,389,920 30,521                
Issuance of ordinary shares (Note 7) 160,624 $ 14   160,610              
Issuance of ordinary shares (Note 7), shares   9,750,000                  
Conversion of ordinary shares into deferred shares, share   (18,262) 78,537                
Effect of corporate reorganization including conversion of preferred share to ordinary share   $ 34 $ 128 (28)              
Effect of Corporate Reorganization including Conversion of Preferred Share to Ordinary Share, shares             (28,250,000) (52,192,070)   (24,412,603)  
Effect of corporate reorganization including conversion of preferred share to ordinary share             $ (36) $ (66)   $ (32)  
Effect of Corporate Reorganization including Conversion of Preferred Share to Ordinary Share, shares   26,481,831 (109,057)                
Share-based compensation expense 6,317     6,317              
Unrealized gain on foreign currency translation (5,686)       (5,686)            
Net loss (61,099)         (61,099)          
Ending balance at Dec. 31, 2021 289,528 $ 54 $ 128 401,821 6,636 (119,111)          
Ending balance, shares at Dec. 31, 2021   40,603,489 1                
Issuance of ordinary shares under employee share purchase plan 1     1              
Issuance of ordinary shares under employee share purchase plan, shares   493                  
Forfeiture of ordinary shares, shares   (6,036)                  
Conversion of ordinary shares into deferred shares, share   334,781                  
Share-based compensation expense 7,022     7,022              
Unrealized gain on foreign currency translation (28,331)       (28,331)            
Net loss (71,176)         (71,176)          
Ending balance at Dec. 31, 2022 $ 197,044 $ 54 $ 128 $ 408,844 $ (21,695) $ (190,287)          
Ending balance, shares at Dec. 31, 2022 0                    
Ending balance, shares at Dec. 31, 2022   40,932,727 1